BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3496216)

  • 1. Role of activated T lymphocytes in mycosis fungoides.
    Wehrmann W; Bauer R; Fuchs D; Hausen A; Reibnegger G; Werner ER; Wachter H
    Eur J Clin Microbiol; 1987 Apr; 6(2):210-1. PubMed ID: 3496216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective costimulation modulators of T cells: A potential treatment for mycosis fungoides and other SALT-proliferating diseases.
    Capella GL
    Med Hypotheses; 2007; 68(2):452. PubMed ID: 16919394
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A therapy for mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K; Zachariae H; Søgaard H
    Arch Dermatol; 1987 Feb; 123(2):160-3. PubMed ID: 3813585
    [No Abstract]   [Full Text] [Related]  

  • 4. Extracutaneous spreading with fatal outcome of mycosis fungoides in a patient treated with ciclosporin A: a word of caution.
    Thomsen K; Wantzin GL
    Dermatologica; 1987; 174(5):236-8. PubMed ID: 3582709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte abnormalities in mycosis fungoides.
    MacKie R; Sless FR; Cochran R; De Sousa M
    Br J Dermatol; 1976 Feb; 94(2):173-8. PubMed ID: 1082769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of mycosis fungoides.
    Girardi M; Heald PW; Wilson LD
    N Engl J Med; 2004 May; 350(19):1978-88. PubMed ID: 15128898
    [No Abstract]   [Full Text] [Related]  

  • 7. Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K
    Acta Derm Venereol; 1980; 60(2):159-61. PubMed ID: 6155025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission in skin infiltrate of a patient with mycosis fungoides treated with cyclosporine.
    Maddox AM; Kahan BD; Tucker S; Kerman R; Jordan RE
    J Am Acad Dermatol; 1985 May; 12(5 Pt 2):952-6. PubMed ID: 3158679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides: lack of helper lymphocytes in lymphocyte-monocyte interactions [proceedings].
    Norris DA
    Br J Dermatol; 1978 Jul; 99(Suppl 16):16. PubMed ID: 308810
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin a (cyclosporine) in the treatment of cutaneous T cell lymphoma (mycosis fungoides).
    Kreis W; Budman DR; Shapiro PE
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1138-40. PubMed ID: 3385033
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte transformation in patients with staged mycosis fungoides and Sézary syndrome.
    du Vivier A; Harper RA; Vonderheid E; Van Scott EJ
    Cancer; 1978 Jul; 42(1):209-13. PubMed ID: 149588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic marker analysis of peripheral blood lymphocytes during extracorporeal photopheresis.
    al-Katib A; Volbergs M; Shearer C; Heilbrun L; Reading B; Sensenbrenner L
    Ann N Y Acad Sci; 1991 Dec; 636():357-9. PubMed ID: 1793220
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of T cell subsets and Langerhans cells in mycosis fungoides, and the effect of PUVA therapy.
    Cox NH; Turbitt ML; Ashworth J; Mackie RM
    Clin Exp Dermatol; 1986 Nov; 11(6):564-8. PubMed ID: 3499264
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycosis fungoides following skin trauma.
    Paul LJ; Duvic M
    J Am Acad Dermatol; 2012 Oct; 67(4):e148. PubMed ID: 22980272
    [No Abstract]   [Full Text] [Related]  

  • 15. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
    Holden CA; Morgan EW; MacDonald DM
    Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological profile of mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K; Ahrons S; Zachariae H
    Clin Exp Immunol; 1982 Nov; 50(2):397-405. PubMed ID: 6983938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current problems in mycosis fungoides and Sézary syndrome.
    Winkelmann RK; Caro WA
    Annu Rev Med; 1977; 28():251-69. PubMed ID: 140621
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunology of mycosis fungoides.
    Tan RS
    Int J Dermatol; 1976 Sep; 15(7):513-4. PubMed ID: 1085759
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor cell characterization in mycosis fungoides.
    Robinowitz BN; Noguchi S; Roenigk HH
    Cancer; 1976 Apr; 37(4):1747-53. PubMed ID: 1083287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.